在注意力障碍的青少年中减少非自杀性自伤的Atomoxetin增剂的有效性:初步研究
Dohyeong Lee1,2, Su A Kwon2, Mee Ae Kim2
1Seoul Puren Psychiatry Clinic, Jeju, Republic of Korea.
Journal of child and adolescent psychopharmacology
|August 20, 2025
概括
在注意力障碍的青少年中,阿托莫克西增强显著降低了非自杀性自我伤害 (NSSI) 的严重程度. 研究结果表明,对伴随性注意力缺陷/多动症 (ADHD) 和NSSI的青少年来说,阿托莫克西可能是有效的.
科学领域:
- 临床心理学
- 儿童和青少年精神病学
- 神经科学
背景情况:
- 非自杀性自伤 (NSSI) 是青少年的一个重大问题,经常与注意力问题同时发生.
- 在患有NSSI的青少年中经常观察到注意力缺陷/多动症 (ADHD),使治疗方法复杂化.
- 对于患有多动性多动症的青少年,现有的NSSI治疗方法需要进一步研究疗效和增强策略.
研究的目的:
- 介绍一项开放性临床试验的方案,该试验旨在研究阿托莫克西作为注意力障碍的青少年NSSI的增强策略.
- 报告关于阿托莫克西降低NSSI严重性和相关症状的初步发现.
- 探索阿托莫克西对伴随性多动症症状和相关心理因素的影响.
主要方法:
- 招募了27名患有NSSI和完全或亚临床ADHD的青少年 (年龄在13-18岁),他们之前没有服用ADHD药物4周.
- 进行了12周的辅助治疗,测量了NSSI的严重程度 (主要结果) 和包括抑郁,焦虑和ADHD症状在内的次要结果.
- 使用标准化诊断工具 (DSM-5,情绪障碍和精神分裂症儿童表) 和结果措施 (关于自伤陈述的清单,CDRS,CDI,SCARED,ARS).
主要成果:
- 23名参与者完成了这项试验,在抑郁症 (CDRS,CDI) 和NSSI严重性 (分别为p < 0. 001,p = 0. 031,p = 0. 007) 上有显著改善.
- 在整个ADHD组中,抑郁症 (CDRS) 和NSSI严重程度显著改善 (p = 0. 017, p = 0. 034).
- 亚临床ADHD组显示抑郁症 (CDRS) 显著改善,NSSI严重程度有所改善 (p = 0. 006,p = 0. 083).
结论:
- 在注意力障碍的青少年中,尤其是伴随性多动症的青少年中,阿托莫克西增强显示有望降低NSSI的严重程度.
- 这些发现支持了阿托莫克西作为有效辅助治疗的潜在作用.
- 需要在更大的受控试验中进行进一步的研究,以确认这些初步发现并建立最佳的治疗方案.
更多相关视频
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
5.8K
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
15.3K
相关概念视频
Attention-Deficit/Hyperactivity Disorder
289
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
289
Antidepressant Drugs: MAOIs and Other Agents
344
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
344
Autism Spectrum Disorder
336
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
336
Electroconvulsive Therapy
185
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
185
Modeling in Therapy
145
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
145
Mania and Antimanic Drugs: Overview
319
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
319
